Literature DB >> 24560174

Squamous cell carcinoma of the pectoralis major myocutaneous flap donor site.

A Mathan Mohan1, B Balaguhan2, Vinod Krishna3, Muralidhara Nagarjuna4.   

Abstract

The pectoralis major myocutaneous flap is considered a workhorse flap in the reconstruction of head and neck defects after cancer ablative surgeries and remains one of the most widely used reconstructive options. Complications at the donor site after the use of this flap, although rare, do occur and are usually restricted to minor infections, hematoma, and seroma formation. Metastasis to the flap donor site is a rare complication with limited documentation. Metastasis at the donor site usually follows local recurrence at the primary site, supporting the probable hypothesis of re-establishment of lymphatic drainage to the primary site by the flap pedicle. Tumor implantation, although a probable cause for metastasis at the donor site, cannot be confidently distinguished from other mechanisms, such as hematogenous spread or lymphogenous metastasis. This report describes a case that supports a seeding or tumor implantation mechanism of metastasis exclusively.
Copyright © 2014 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24560174     DOI: 10.1016/j.joms.2013.12.021

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  2 in total

1.  Exploring an Unfathomed Entiry: A Pooled Analysis of Solitory Skeletal Muscle Metastasis from Head and Neck Squamous Cell Carcinoma.

Authors:  Dharma Ram Poonia; Suhas Kodasoge Rajappa; Ajay K Dewan; Amit Sehrawat; Chaturbhuj Agrawal; Koyyala Venkata Pradeep Babu
Journal:  J Maxillofac Oral Surg       Date:  2020-04-04

2.  Primary squamous cell carcinoma in the chest wall mimicking abscess.

Authors:  Yoon Sang Shin; Chang Hwan Choi; Youn Jeong Kim; Yeo Ju Kim; Kyung Hee Lee; Mi Young Kim
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.